Alexander's Inc. (ALX) is Trading Lower on Unusual Volume for January 26

Equities Staff  |

Alexander's Inc. (ALX) experienced unusually high volume on Jan. 26, as the stock lost 0.52% to a closing price of $370.00. The stock saw 19,332 shares trade hands over the course of the day on 344 trades. Given that the stock’s average daily volume over the last month has been 4,731 shares a day, this represents a pretty substantial spike over the norm.

Alexander's Inc. has a P/B ratio of 5.47. It also has a P/E ratio of 26.6. The stock has traded between $483.00 and $356.00 over the last 52-weeks, its 50-day SMA is now $385.15, and its 200-day SMA $391.72.

Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. The Company is managed by, and its properties are leased and developed by, Vornado Realty Trust.

Headquartered in Paramus, NJ, Alexander's Inc. has 68 employees and is currently under the leadership of CEO Steven Roth.

For a complete fundamental analysis analysis of Alexander's Inc., check out’s Stock Valuation Analysis report for ALX. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update. Mr. Corin discusses the company's recent acquisition of Metastron, a radiopharmaceutical for cancer bone pain. Q BioMed is dedicated to providing these target assets; strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential, enabling them to provide products to patients in need?.

Emerging Growth

Singlepoint Inc

SinglePoint Inc is a mobile technology company engaged in mobile payments, mobile giving, and mobile bidding. It operates mobile commerce and communications platform to accept mobile credit card payments.